GSA models
experimental models of GBM
molecular basis of GBM heterogeneity
molecular subtypes
GBM Subtype Avatars models
Mesenchymal GBM subtypes
GBM clinical management
molecular fingerprinting
GSA transcriptome
molecular features
molecular level
exclusive genetic lesions
appropriate genetic lesions
Glioblastoma Subtype Avatar models
gene expression
personalized biology
art genetic screens
patient benefit
engineered NSC
patient-derived xenografts
DNA methylation
reflecting patients
Glioblastoma Multiforme
targeted patients
tumor-specific vulnerabilities
personalized entry point
CRISPRi screening approach
common primary brain tumor
adult human neural stem cells
Target Discovery
similar histopathology
agents
patientsâ€™ response
dismal disease
resulting tumors
immunophenotypic tracing
effective therapies
Proneural
high-grade gliomas
epigenomic profiling
current standard of care
synthetic lethal interactions
way
available treatments
rapid Translation
major challenges
state
drug targets
immunocompromised rats
number aberrations
intervention studies
Oncology
questions
rise
biopsies
mutations
chosen therapy
resistance
Evidence
profiles